Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
ULYSSE
Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection
1 other identifier
interventional
4,000
1 country
1
Brief Summary
Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started May 2022
Longer than P75 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 4, 2022
CompletedStudy Start
First participant enrolled
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 5, 2042
November 21, 2025
November 1, 2025
10 years
February 14, 2022
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants registered in the lung cancer database
cohort open to recruitment during 10 years with 10 years of patients follow-up
20 years
Study Arms (1)
Cohort of Adults with lung cancer
EXPERIMENTALPatients newly diagnosed with lung cancer.
Interventions
One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer
to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.
Eligibility Criteria
You may qualify if:
- Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma…
- Diagnosis can be done:
- By cytology or pathologic assessment
- Or by multidisciplinary team meeting decision:
- Irradiation without morpho-metabolic sampling
- Treatment without sampling based on non-invasive molecular data
You may not qualify if:
- \- Refusal to participate
- For optional blood sampling :
- \< 30 kg for blood collection
- No blood sampling schedule for care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2022
First Posted
March 4, 2022
Study Start
May 5, 2022
Primary Completion (Estimated)
May 5, 2032
Study Completion (Estimated)
May 5, 2042
Last Updated
November 21, 2025
Record last verified: 2025-11